The cellular and genomic response of rat dopaminergic neurons (N27) to coated nanosilver.

This study examined if nanosilver (nanoAg) of different sizes and coatings were differentially toxic to oxidative stress-sensitive neurons. N27 rat dopaminergic neurons were exposed (0.5-5 ppm) to a set of nanoAg of different sizes (10nm, 75 nm) and coatings (PVP, citrate) and their physicochemical, cellular and genomic response measured. Both coatings retained their manufactured sizes in culture media, however, the zeta potentials of both sizes of PVP-coated nanoAg were significantly less electronegative than those of their citrate-coated counterparts. Markers of oxidative stress, measured at 0.5-5 ppm exposure concentrations, indicated that caspase 3/7 activity and glutathione levels were significantly increased by both sizes of PVP-coated nanoAg and by the 75 nm citrate-coated nanoAg. Both sizes of PVP-coated nanoAg also increased intra-neuronal nitrite levels and activated ARE/NRF2, a reporter gene for the oxidative stress-protection pathway. Global gene expression on N27 neurons, exposed to 0.5 ppm for 8h, indicated a dominant effect by PVP-coated nanoAg over citrate. The 75 nm PVP-coated material altered 196 genes that were loosely associated with mitochondrial dysfunction. In contrast, the 10nm PVP-coated nanoAg altered 82 genes that were strongly associated with NRF2 oxidative stress pathways. Less that 20% of the affected genes were shared by both sizes of PVP-coated nanoAg. These cellular and genomic findings suggest that PVP-coated nanoAg is more bioactive than citrate-coated nanoAg. Although both sizes of PVP-coated nanoAg altered the genomic expression of N27 neurons along oxidative stress pathways, exposure to the 75 nm nanoAg favored pathways associated with mitochondrial dysfunction, whereas the 10nm PVP-coated nanoAg affected NRF2 neuronal protective pathways.

[1]  K. Double,et al.  Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions? , 2010, Progress in Neurobiology.

[2]  J. Andersen,et al.  Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. , 2006, Free radical biology & medicine.

[3]  W. D. de Jong,et al.  Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment , 2009 .

[4]  P. Oh,et al.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung , 2007, Nature Biotechnology.

[5]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[6]  M. Odén,et al.  Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization , 2012, Nanoscale Research Letters.

[7]  Steven O Simmons,et al.  Cellular stress response pathway system as a sentinel ensemble in toxicological screening. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  Ylä-HerttualaSeppo,et al.  Does Nrf2 gene transfer facilitate recovery after contusion spinal cord injury , 2014 .

[9]  T. Xi,et al.  Distribution, translocation and accumulation of silver nanoparticles in rats. , 2009, Journal of nanoscience and nanotechnology.

[10]  Xinkun Wang,et al.  Frontiers in Aging Neuroscience Aging Neuroscience Review Article , 2022 .

[11]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[12]  Andreas Luch,et al.  Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications , 2013, Materials.

[13]  P. Maher,et al.  Glutathione production is regulated via distinct pathways in stressed and non-stressed cortical neurons , 2008, Brain Research.

[14]  J. Lotharius,et al.  Inflammation in Parkinson's disease: causative or epiphenomenal? , 2007, Sub-cellular biochemistry.

[15]  Sven Frokjaer,et al.  Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.

[16]  Navid B. Saleh,et al.  Nanosize Titanium Dioxide Stimulates Reactive Oxygen Species in Brain Microglia and Damages Neurons in Vitro , 2007, Environmental health perspectives.

[17]  Kirk G Scheckel,et al.  Surface charge-dependent toxicity of silver nanoparticles. , 2011, Environmental science & technology.

[18]  Martha L. Carvour,et al.  Chronic Low‐Dose Oxidative Stress Induces Caspase‐3‐Dependent PKCδ Proteolytic Activation and Apoptosis in a Cell Culture Model of Dopaminergic Neurodegeneration , 2008, Annals of the New York Academy of Sciences.

[19]  Edwin R Chapman,et al.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. , 2008, Molecular biology of the cell.

[20]  A. Paillard,et al.  Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. , 2007, International journal of pharmaceutics.

[21]  Paul R. Lockman,et al.  Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.

[22]  María Vallet-Regí,et al.  The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles , 2010 .

[23]  J. Paik,et al.  Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. , 2005, Cellular signalling.

[24]  Eric A. Johnson,et al.  SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons , 2010, PLoS pathogens.

[25]  R. L. Jones,et al.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. , 2008, The journal of physical chemistry. B.

[26]  R. Hurt,et al.  Ion release kinetics and particle persistence in aqueous nano-silver colloids. , 2010, Environmental science & technology.

[27]  L. Liz‐Marzán,et al.  Formation of PVP-Protected Metal Nanoparticles in DMF , 2002 .

[28]  M. Sawada,et al.  Cellular and Molecular Mechanisms of Parkinson’s Disease: Neurotoxins, Causative Genes, and Inflammatory Cytokines , 2006, Cellular and Molecular Neurobiology.

[29]  S. Hester,et al.  The Cellular and Genomic Response of an Immortalized Microglia Cell Line (BV2) to Concentrated Ambient Particulate Matter , 2007, Inhalation toxicology.

[30]  M. Niso-Santano,et al.  Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. , 2009, Neurotoxicology.

[31]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[32]  A. Genaidy,et al.  An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: a systematic review and critical appraisal of peer-reviewed scientific papers. , 2010, The Science of the total environment.

[33]  T. González-Hernández,et al.  Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease , 2010, Front. Neuroanat..

[34]  J. Wakefield,et al.  NRF2 Oxidative Stress Induced by Heavy Metals is Cell Type Dependent , 2011, Current chemical genomics.

[35]  G. Sotiriou,et al.  Antibacterial activity of nanosilver ions and particles. , 2010, Environmental science & technology.

[36]  D. Choi,et al.  Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson’s disease , 2007, Neurobiology of Disease.

[37]  Iseult Lynch,et al.  Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.

[38]  Aparna Watal,et al.  Nanosilver and Global Public Health: International Regulatory Issues , 2010, Nanomedicine.

[39]  Tanapon Phenrat,et al.  Partial oxidation ("aging") and surface modification decrease the toxicity of nanosized zerovalent iron. , 2009, Environmental science & technology.

[40]  K. Chen,et al.  Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. , 2011, Environmental science & technology.

[41]  Y. Levin,et al.  Smoluchowski equation and the colloidal charge reversal. , 2006, The Journal of chemical physics.

[42]  X. Chen,et al.  Nanosilver: a nanoproduct in medical application. , 2008, Toxicology letters.

[43]  Wolfgang J. Parak,et al.  The Toxicity of Silver Nanoparticles Depends on Their Uptake by Cells and Thus on Their Surface Chemistry , 2013 .

[44]  DelindaA . Johnson,et al.  Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  G. Rotilio,et al.  Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells , 2011, Journal of Cell Science.

[46]  Merle G Paule,et al.  Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  April Z Gu,et al.  Mechanistic toxicity assessment of nanomaterials by whole-cell-array stress genes expression analysis. , 2010, Environmental science & technology.

[48]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[49]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[50]  M. Young,et al.  Brain Activation of Monocyte Lineage Cells: Brain-Derived Soluble Factors Differentially Regulate BV2 Microglia and Peripheral Macrophage Immune Functions , 2003, Neuroimmunomodulation.

[51]  Beena Vallanat,et al.  The Physicochemistry of Capped Nanosilver Predicts Its Biological Activity in Rat Brain Endothelial Cells (RBEC4) , 2014 .

[52]  Saber M Hussain,et al.  Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. , 2009, Neurotoxicology.

[53]  Navid B. Saleh,et al.  Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. , 2006, Environmental science & technology.

[54]  G. Oberdörster,et al.  Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles , 1996 .

[55]  W. Kreyling,et al.  Ultrafine particle-lung interactions: does size matter? , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[56]  M. Halloran,et al.  The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration , 2013, International journal of cell biology.

[57]  Michael Giersig,et al.  Formation of Colloidal Silver Nanoparticles: Capping Action of Citrate , 1999 .

[58]  P. Riederer,et al.  Degeneration of neuronal cells due to oxidative stress--microglial contribution. , 2002, Parkinsonism & related disorders.

[59]  Naomi Lubick,et al.  Nanosilver toxicity: ions, nanoparticles--or both? , 2008, Environmental science & technology.

[60]  Marcel Leist,et al.  The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. , 2009, ALTEX.

[61]  Ralph Weissleder,et al.  Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers , 2005, Chembiochem : a European journal of chemical biology.

[62]  Syed F. Ali,et al.  Methamphetamine Induces Autophagy and Apoptosis in a Mesencephalic Dopaminergic Neuronal Culture Model , 2006, Annals of the New York Academy of Sciences.

[63]  Y. Li,et al.  Identification of jun-B as third member in human antioxidant response element-nuclear proteins complex. , 1992, Biochemical and biophysical research communications.

[64]  Bernd Nowack,et al.  120 years of nanosilver history: implications for policy makers. , 2011, Environmental science & technology.

[65]  Timothy H Murphy,et al.  Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo* , 2005, Journal of Biological Chemistry.

[66]  Tung-Sheng Shih,et al.  The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. , 2008, Toxicology letters.

[67]  E. Hirsch,et al.  Neuronal vulnerability in Parkinson's disease. , 1997, Journal of neural transmission. Supplementum.

[68]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[69]  U. Vogel,et al.  Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate , 2011, Particle and Fibre Toxicology.

[70]  G. Xiao,et al.  Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics , 2013, International journal of cell biology.

[71]  B. Halliwell,et al.  Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.

[72]  Zhiqiang Hu,et al.  Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. , 2008, Environmental science & technology.

[73]  G. Han,et al.  Epac1‐mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells , 2005, Journal of neuroscience research.

[74]  Zhen-Yu Zhou,et al.  SV2 Acts via Presynaptic Calcium to Regulate Neurotransmitter Release , 2010, Neuron.

[75]  Jau-Shyong Hong,et al.  Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. , 2006, Journal of neural transmission. Supplementum.

[76]  James Douglas Engel,et al.  Nrf2 Transcriptionally Activates the mafG Gene through an Antioxidant Response Element* , 2005, Journal of Biological Chemistry.

[77]  A. Kanthasamy,et al.  Tyrosine Phosphorylation Regulates the Proteolytic Activation of Protein Kinase Cδ in Dopaminergic Neuronal Cells*[boxs] , 2005, Journal of Biological Chemistry.

[78]  Manisha N. Patel,et al.  1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons. , 2007, Toxicology and applied pharmacology.

[79]  R. Hill,et al.  Nanoparticle ζ -potentials. , 2012, Accounts of chemical research.

[80]  K. Becker,et al.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: Relevance to oxidative damage in Parkinson's disease , 2007, Neurochemistry International.

[81]  P. P. Chang,et al.  Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. , 2006, Cancer research.

[82]  Ying Liu,et al.  Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. , 2011, Small.

[83]  P. Phelan,et al.  Widespread Distribution of Synaptophysin, a Synaptic Vesicle Glycoprotein, in Growing Neurites and Growth Cones , 1992, The European journal of neuroscience.

[84]  K W Lem,et al.  Use of nanosilver in consumer products. , 2012, Recent patents on nanotechnology.

[85]  H. Autrup,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 , 2011, Archives of Toxicology.